Clinical trials
Cytomegalovirus Infections trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2014 | 2 |
| 2016 | 1 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Unknown status | 3 |
| Not yet recruiting | 2 |
| Recruiting | 2 |
| Terminated | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 5 |
| Maimónides Biomedical Research Institute of Córdoba | 3 |
| AlloVir | 1 |
| Edoardo Melilli | 1 |
| Emilio Bouza | 1 |
| Fundacio Catalana de Pneumologia | 1 |
| Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | 1 |
| Genentech, Inc. | 1 |
| Hospital Universitari de Bellvitge | 1 |
| Hospital Universitario 12 de Octubre | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cytomegalovirus Infections | 26 |
| Adenoviridae Infections | 2 |
| Epstein-Barr Virus Infections | 2 |
| Multiple Acyl Coenzyme A Dehydrogenase Deficiency | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| DNA Virus Infections | 1 |
| Hepatitis C | 1 |
| Infections | 1 |
| Pneumonia | 1 |
| Tuberculosis | 1 |
Trials
Showing 26 to 26 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.